I recently had the privilege of being guest editor for an issue of Medical Writing, the journal of the European Medical Writers Association. It was a theme issue, with the theme being "good pharma".
There is a lot of talk about bad pharma these days, some of it justified, but much of it hyped up. After all, bashing the pharmaceutical industry is always a great way to sell books or newspapers. So we at EMWA thought it might be interesting to look at things from a different perspective.
EMWA members can read the articles here, though sadly everyone else will find themselves on the wrong side of a paywall (I know, I know, but I don't make the rules). The articles are also available, with abstracts, here, though the paywall still applies to the full articles.
Though I can't help you with the paywall for the rest of the issue, I can at least share my guest editorial with you. If other authors make their articles available on their websites, I'll post links below.
Update 6 December 2013, 11.20 am:
As promised, some links:
The Stern & Lemmens article on legal remedies for ghostwriting was previously published in the open access journal PLoS Medicine, and you can read it here.
Stephen Senn has posted his Bad Karma article on his personal website.
Hayley Johnson's article on the challenges for community pharmacists of engaging with evidence-based medicine is here.